Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Antikörper:
anti-Rat (Rattus) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Cow (Bovine) Polyclonal PPARD Primary Antibody für WB - ABIN2780303
Nadra, Anghel, Joye, Tan, Basu-Modak, Trono, Wahli, Desvergne: Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. in Molecular and cellular biology 2006
Show all 5 Pubmed References
Chimpanzee Polyclonal PPARD Primary Antibody für ELISA, WB - ABIN2476190
Bhatt, Wright: Concept learning by monkeys with video picture images and a touch screen. in Journal of the experimental analysis of behavior 1992
Show all 3 Pubmed References
Human Polyclonal PPARD Primary Antibody für IP, ELISA - ABIN268777
Castillero, Alamdari, Aversa, Gurav, Hasselgren: PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting. in PLoS ONE 2013
Show all 2 Pubmed References
Human Monoclonal PPARD Primary Antibody für PLA, ELISA - ABIN562332
Holloway, Perry, Thrush, Heigenhauser, Dyck, Bonen, Spriet: PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein. in American journal of physiology. Endocrinology and metabolism 2008
Chicken Polyclonal PPARD Primary Antibody für ELISA, WB - ABIN2476188
Krogsdam, Nielsen, Neve, Holst, Helledie, Thomsen, Bendixen, Mandrup, Kristiansen: Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. in The Biochemical journal 2002
Human Polyclonal PPARD Primary Antibody für ELISA, WB - ABIN185282
Park, Vogelstein, Kinzler: Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. in Proceedings of the National Academy of Sciences of the United States of America 2001
Show all 2 Pubmed References
Gerbil Polyclonal PPARD Primary Antibody für ELISA, IHC - ABIN4347008
Falcone, Florio, Di Giacomo, Benedetti, Cristiano, Antonosante, Fidoamore, Massimi, Alecci, Ippoliti, Giordano, Cimini: PPARβ/δ and γ in a rat model of Parkinson's disease: possible involvement in PD symptoms. in Journal of cellular biochemistry 2015
PPARD rs7770619 is a novel candidate variant for impaired fasting glucose and type 2 diabetes and shows association with malondialdehyde levels.
The negative responders for aerobic training are carriers of the PPARD rs2267668 G allele. The best responders to aerobic training are PPARD rs1053049 TT and rs2267668 AA.
The current results suggest that A/A carriers of PPAR-delta SNP (rs2267668) may enjoy fewer beneficial effects of exercise-centered lifestyle intervention on anthropometric indices and blood measurements.
Polymorphism of PPARD is associated with late onset of type 2 diabetes mellitus.
findings suggest that PPARdelta conditions CLL cells to survive in harsh microenvironmental conditions by reducing oxidative stress and increasing metabolic efficiency.
Here, theauthors describe a novel PPARbeta/delta-dependent molecular cascade involving TGFbeta1 (zeige TGFB1 Antikörper) and miR (zeige MLXIP Antikörper)-21-3p, which is activated in the epidermis in response to UV exposure.
findings identified previously unrecognized role of IP-PPARdelta signal transduction pathway in the production of sAPPalpha in cerebral microvasculature.
PPAR-delta activation prevents in-stent restenosis and stent thrombosis.
findings identify LPCAT3 (zeige LPCAT3 Antikörper) as a direct PPARdelta target gene and suggest a novel function of PPARdelta in regulation of phospholipid metabolism through LPCAT3 (zeige LPCAT3 Antikörper).
The minor allele of rs2016520 and rs9794 in PPAR-delta and interaction between rs2016520 and non-smoking were associated with decreased risk of CVD.
The results confirmed that silencing miR29a induced a decrease in glucose transport and affected lipid metabolism in PAtreated C2C12 cells, and therefore may be involved in insulin (zeige INS Antikörper) resistance by targeting PPARdelta in skeletal muscle.
Deletion of intestinal PPARdelta protects against diet-induced obesity, insulin (zeige INS Antikörper) resistance and dyslipidemia.
Data suggest that interaction of Ppard with Tcptp45 blunts insulin (zeige INS Antikörper) resistance and leads to retention of Tcptp45 in nucleus of hepatocytes, myotubes, and adipocytes; alteration of such interactions may be involved in insulin (zeige INS Antikörper) resistance observed in obesity. (Ppard = peroxisome proliferator activator receptor delta; Tcptp45 = protein tyrosine phosphatase non-receptor type 2 (zeige PTPN2 Antikörper) [Ptpn2 (zeige PTPN2 Antikörper)], 45kDa (zeige NFE2 Antikörper) alternative splicing variant)
CRY1 (zeige CRY1 Antikörper)/2 seem to repress a distinct subset of PPAR delta target genes in muscle compared to the co-repressor NCOR1 (zeige NCOR1 Antikörper). In vivo, genetic disruption of Cry1 (zeige CRY1 Antikörper) and Cry2 (zeige CRY2 Antikörper) enhances sprint exercise performance in mice.
CD36 (zeige CD36 Antikörper) is essential for endurance improvement, changes in whole-body metabolism, and efficient peroxisome-proliferator activated receptors (PPAR (zeige PPARA Antikörper))-related transcriptional responses in the muscle with exercise training.
Exhaustion of systemic glucose limits endurance exercise. PPARdelta regulates substrate utilization without mitochondrial biogenesis. PPARdelta represses glycolytic genes in muscle to slow glucose consumption. Glucose sparing by PPARdelta dramatically extends running time.
The HFHC diet polarized the liver toward a proinflammatory M1 state, which was reversed by GW1516 intervention. Thus, PPARdelta agonist treatment inhibits the progression of preestablished hepatic steatosis.
data suggested that PPARbeta-regulated PDK1 (zeige PDPK1 Antikörper)/Akt (zeige AKT1 Antikörper) and E2f (zeige E2F1 Antikörper) signaling that controls metabolism and proliferation is involved in the normal progression of liver regeneration
Since the R6/2 mice represent a 'truncated' huntingtin (Htt (zeige HTT Antikörper)) mouse model of Huntington's disease (HD), we tested the efficacy of bezafibrate in a 'full-length' Htt (zeige HTT Antikörper) mouse model, the BACHD mice. Bezafibrate treatment restored the impaired PPARg (zeige PPARG Antikörper), PPARd, PGC (zeige PGC Antikörper)-1a signaling pathway, enhanced mitochondrial biogenesis and improved antioxidant defense in the striatum of BACHD mice
we demonstrated that by modulating mitochondrial energy metabolism through Mfn2 (zeige MFN2 Antikörper) and mitochondrial Ca2 (zeige CA2 Antikörper)+, PPAR-b took an important role in neuronal differentiation induced by flavonoid compound 4a
Gene expression of the carnitine transporter OCTN2 (zeige SLC22A5 Antikörper) and carnitine transport are regulated by PPARbeta/delta in bovine cells.
Our results provide novel insights into regulation of PPAR (zeige PPARA Antikörper) expression in ovarian follicles. We observed that FSH (zeige BRD2 Antikörper) increased mRNA and protein expression of all PPARs isoforms, while LH only increased PPAR alpha (zeige PPARA Antikörper) and gamma. Steroids like progesterone and estradiol increased expression of PPAR alpha (zeige PPARA Antikörper) and gamma without affecting the beta isoform, while testosterone had no effect on all PPARs expression.
provide evidence that PPARD G32E is the variation underlying the ear size QTL
study provides evidence for an association between PPARD and backfat thickness.
PPAR (zeige PPARA Antikörper) profiles in bladder smooth muscle (BSM (zeige MUC19 Antikörper)) may contribute to the susceptibility of BSM (zeige MUC19 Antikörper) to lipotoxicity in the metabolic syndrome.
Overexpression of PPARdelta inhibits myotube formation and also enhances adipocyte differentiation in cultured mouse myoblasts.
This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) family. PPARs are nuclear hormone receptors that bind peroxisome proliferators and control the size and number of peroxisomes produced by cells. PPARs mediate a variety of biological processes, and may be involved in the development of several chronic diseases, including diabetes, obesity, atherosclerosis, and cancer. This protein is a potent inhibitor of ligand-induced transcription activity of PPAR alpha and PPAR gamma. It may function as an integrator of transcription repression and nuclear receptor signaling. The expression of this gene is found to be elevated in colorectal cancer cells. The elevated expression can be repressed by adenomatosis polyposis coli (APC), a tumor suppressor protein related to APC/beta-catenin signaling pathway. Knockout studies in mice suggested the role of this protein in myelination of the corpus callosum, lipid metabolism, and epidermal cell proliferation. Alternate splicing results in multiple transcript variants.
, nuclear hormone receptor 1
, nuclear receptor subfamily 1 group C member 2
, peroxisome proliferator-activated nuclear receptor beta/delta variant 2
, peroxisome proliferator-activated receptor beta
, Peroxisome proliferator-activated receptor beta
, peroxisome proliferator-activated receptor delta
, peroxisome proliferative activated receptor, delta
, peroxisome proliferator-activated receptor delta-like
, peroxisome proliferator activated receptor delta
, peroxisome proliferator activator receptor beta
, peroxisome proliferator activator receptor, delta
, peroxisome proliferator activator receptor delta
, peroxisome proliferator activated receptor delta/beta